Patents by Inventor Miso Sabovic

Miso Sabovic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9498464
    Abstract: The present invention relates to a pharmaceutical combination composition comprising at least one renin-angiotensin-aldosterone system inhibitor in a subtherapeutic daily dose and at least one HMG-CoA reductase inhibitor in a subtherapeutic daily dose for use in maintaining or improving the functional and morphological properties of the arterial wall in a subject having at least one cardiovascular disorder or having at least one risk factor for cardiovascular disorder.
    Type: Grant
    Filed: December 7, 2012
    Date of Patent: November 22, 2016
    Assignee: ARTSKIN D.O.O.
    Inventor: Miso Sabovic
  • Publication number: 20140323536
    Abstract: The present invention relates to a pharmaceutical combination composition comprising at least one renin-angiotensin-aldosterone system inhibitor in a subtherapeutic daily dose and at least one HMG-CoA reductase inhibitor in a subtherapeutic daily dose for use in maintaining or improving the functional and morphological properties of the arterial wall in a subject having at least one cardiovascular disorder or having at least one risk factor for cardiovascular disorder.
    Type: Application
    Filed: December 7, 2012
    Publication date: October 30, 2014
    Applicant: ARTSKIN d.o.o.
    Inventor: Miso Sabovic
  • Publication number: 20140107170
    Abstract: The present invention relates to a topical composition comprising at least one angiotensin II receptor antagonist and at least one antioxidant.
    Type: Application
    Filed: May 4, 2012
    Publication date: April 17, 2014
    Inventor: Miso Sabovic
  • Publication number: 20140005412
    Abstract: The present invention relates to a pharmaceutical combination composition comprising at least one HMG-CoA reductase inhibitor in a subtherapeutic dose and which is designed to prevent and/or to reduce the ageing of the body, particularly for use in prevention, reduction or reversal of arterial ageing in apparently healthy subjects.
    Type: Application
    Filed: February 28, 2012
    Publication date: January 2, 2014
    Applicant: FARMICOM PHARMACEUTICAL COMPANY D.O.O.
    Inventor: Miso Sabovic
  • Publication number: 20130338203
    Abstract: The present invention relates to a pharmaceutical combination composition comprising at least one renin-angiotensin-aldosterone system inhibitor in a subtherapeutic daily dose and at least one HMG-CoA reductase inhibitor in a subtherapeutic daily dose for use in prevention, reduction or reversal of arterial ageing in apparently healthy subjects.
    Type: Application
    Filed: February 28, 2012
    Publication date: December 19, 2013
    Applicant: FARMICOM PHARMACEUTICAL COMPANY D.O.O.
    Inventor: Miso Sabovic
  • Publication number: 20090023691
    Abstract: The present invention relates to the field of ageing, particularly to the prevention and/or treatment of ageing process and disorders caused by ageing and particularly to the prevention and/or treatment of atherosclerosis, neurodegenerative disorders and malignant diseases. A composition is provided, which comprises four or more active ingredients to reduce or suppress the ageing process or symptoms associated therewith.
    Type: Application
    Filed: April 7, 2005
    Publication date: January 22, 2009
    Inventor: Miso Sabovic